Physician profile
Amanda Langkop
NPI 1629835541
$1,575.53
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $61.97 · 2024: $1,514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,575.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $300.80 | 2024 | Emgality, Kisunla, Amyvid |
| Medtronic, INC. | $265.13 | 2023-2024 | Intellis Adaptivestim, Onyx Frontier, Solitaire X |
| Merz Pharmaceuticals, LLC | $198.84 | 2024 | Xeomin, Ampyra, Inbrija |
| Abbvie INC. | $147.00 | 2024 | |
| Pfizer INC. | $143.24 | 2024 | |
| Lundbeck LLC | $137.88 | 2024 | Vyepti |
| Biogen, INC. | $114.32 | 2024 | Leqembi, Tysabri |
| Novartis Pharmaceuticals Corporation | $80.05 | 2024 | |
| Neurelis, INC. | $64.44 | 2024 | Valtoco |
| Emd Serono, INC. | $50.88 | 2024 | |
| Vanda Pharmaceuticals INC. | $47.94 | 2024 | Ponvory |
| Angiodynamics, INC. | $25.01 | 2024 | Soft-Vu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Langkop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.